EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

In vitro Screening for Synergistic Polymyxin B-Based Combinations Against KPC- Producing Carbapenem-Resistant Klebsiella pneumoniae

Menghan Lv, Hanxi Yi iD, Yalan Liu, Yehua Xie, Zeneng Cheng, Feifan Xie iD, Sanwang Li

Drug Design, Development and Therapy · 2026-01 · Volume 20 · 1-12

DOI: 10.2147/dddt.s574985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-01. Verfasst von Menghan Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, People's Republic o…. Hauptthemen laut MEDLINE: Polymyxin B, Klebsiella pneumoniae, Anti-Bacterial Agents, Carbapenems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyxin BKlebsiella pneumoniaeAnti-Bacterial AgentsCarbapenemsbeta-LactamasesMicrobial Sensitivity TestsDrug SynergismDose-Response Relationship, DrugHumansThird Generation Cephalosporins

Stichwörter der Autor:innen

carbapenem-resistant Klebsiella pneumoniaecombination therapypolymyxin Btime-kill assay

Substanzen

Polymyxin BAnti-Bacterial AgentsCarbapenemsbeta-LactamasesThird Generation Cephalosporins

Autor:innen und Institutionen

  • Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, People's Republic of China.
  • Department of Pathology, School of Basic Medical Science, Central South University, Changsha, People's Republic of China.
  • Certara (Shanghai) Pharmaceutical Consulting Co., Ltd, Shanghai, People's Republic of China.
  • Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, People's Republic of China.
  • Institute of Clinical Pharmacy, Central South University, Changsha, People's Republic of China.

ORCID-Profile: Hanxi Yi, Feifan Xie

Zitieren

APA

Lv, M., Yi, H., Liu, Y., Xie, Y., Cheng, Z., Xie, F., & Li, S. (2026). In vitro Screening for Synergistic Polymyxin B-Based Combinations Against KPC- Producing Carbapenem-Resistant Klebsiella pneumoniae. Drug Design, Development and Therapy, Volume 20, 1-12. https://doi.org/10.2147/dddt.s574985

Vancouver

Lv M, Yi H, Liu Y, Xie Y, Cheng Z, Xie F, et al. In vitro Screening for Synergistic Polymyxin B-Based Combinations Against KPC- Producing Carbapenem-Resistant Klebsiella pneumoniae. Drug Design, Development and Therapy. 2026;Volume 20:1-12. doi:10.2147/dddt.s574985

BibTeX
@article{Lv2026,
  author = {Lv, Menghan and Yi, Hanxi and Liu, Yalan and Xie, Yehua and Cheng, Zeneng and Xie, Feifan and Li, Sanwang},
  title = {In vitro Screening for Synergistic Polymyxin B-Based Combinations Against KPC- Producing Carbapenem-Resistant Klebsiella pneumoniae},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--12},
  doi = {10.2147/dddt.s574985}
}
Kostenlos starten →